| __timestamp | Ionis Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 293000 |
| Thursday, January 1, 2015 | 322292000 | 1002000 |
| Friday, January 1, 2016 | 344320000 | 888000 |
| Sunday, January 1, 2017 | 374644000 | 19623000 |
| Monday, January 1, 2018 | 414604000 | 30421000 |
| Tuesday, January 1, 2019 | 466000000 | 34794000 |
| Wednesday, January 1, 2020 | 535000000 | 28304000 |
| Friday, January 1, 2021 | 643000000 | 56886000 |
| Saturday, January 1, 2022 | 833000000 | 100894000 |
| Sunday, January 1, 2023 | 899625000 | 159765000 |
In pursuit of knowledge
In the ever-evolving biotech industry, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Ionis Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Ionis Pharmaceuticals consistently increased its R&D budget, culminating in a 272% rise, reaching nearly $900 million by 2023. This robust investment underscores Ionis's commitment to pioneering new therapies. In contrast, Viridian Therapeutics, while starting with modest R&D expenses, has shown a remarkable growth trajectory, with a staggering 54,000% increase over the same period, reaching approximately $160 million in 2023.
These trends highlight the dynamic nature of R&D strategies in the biotech sector, where both established and emerging companies are vying for breakthroughs that could redefine healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Viridian Therapeutics, Inc.
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
R&D Insights: How Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds